Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
Clinical trial NCT05359068 · COMPLETED
Trial details
- NCT number
- NCT05359068
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2023-12-26
- Enrollment
- 957
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.